Jump to main content
Jump to site search

Issue 45, 2018
Previous Article Next Article

Platelets and their biomimetics for regenerative medicine and cancer therapies

Author affiliations

Abstract

Platelets, circulating blood cells derived from megakaryocytes, play a key role in various physical activities, including coagulation, hemostasis, the body's innate immune response, and cancer metastasis. By taking advantage of their key traits, researchers have developed strategies to exploit platelets and platelet-mimicking nanoassemblies to treat a number of conditions, including wounds, cancers, and bacterial infections. Compared to traditional polymer, liposome, and inorganic nanoparticle-based delivery systems, platelets and platelet-mimicking vehicles hold many advantages. Among these are their enhanced circulation time, their large volumes and surface areas for drug loading or conjugation, and their inherent ability to target some diseases. In this review, we will highlight the recent progress made in the development of disease-targeting platelets and platelet-mimicking vehicles as therapeutic platforms.

Graphical abstract: Platelets and their biomimetics for regenerative medicine and cancer therapies

Back to tab navigation

Article information


Submitted
31 Aug 2018
Accepted
22 Oct 2018
First published
22 Oct 2018

J. Mater. Chem. B, 2018,6, 7354-7365
Article type
Review Article

Platelets and their biomimetics for regenerative medicine and cancer therapies

Z. Li, S. Hu and K. Cheng, J. Mater. Chem. B, 2018, 6, 7354
DOI: 10.1039/C8TB02301H

Social activity

Search articles by author

Spotlight

Advertisements